{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:51:46Z","timestamp":1781635906797,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Primary nephrotic syndrome (PNS) is a common glomerular disorder in children. Despite significant advances in glucocorticoid therapy, considerable challenges remain in the early diagnosis and prognostic management of PNS. Elevated miR-551b-5p expression has been detected in the PNS. This study aims to further explore the role of miR-551b-5p in the onset and progression of PNS and its potential mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 107 patients with primary nephrotic syndrome (PNS) and 99 healthy volunteers (HV) were included in this study. And the PNS group was further divided into subgroups with favorable (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200976) and poor (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200931) prognosis. The expression of miR-551b-5p in the PNS and the poor prognosis group was quantified using qRT-PCR. The predictive capability of miR-551b-5p for the occurrence and poor prognosis of PNS was evaluated. The effects of miR-551b-5p knockdown on podocyte growth and inflammatory injury were examined. The interaction between miR-551b-5p and CD2AP was verified via database and luciferase assay.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>miR-551b-5p is obviously elevated in PNS and the poor prognosis group. miR-551b-5p exhibits strong diagnostic capability for both the onset and poor prognosis of pediatric PNS. High miR-551b-5p expression is an independent risk factor for poor prognosis in pediatric PNS patients. miR-551b-5p downregulation potently promotes podocyte proliferation and reduces apoptosis, and improves intracellular inflammatory responses and oxidative stress levels. Furthermore, CD2AP is a direct target of miR-551b-5p, and this regulatory axis synergistically contributes to the pathogenesis and progression of PNS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>miR-551b-5p is a potential biomarker for predicting the occurrence and poor prognosis of PNS. miR-551b-5p promotes the onset and progression of PNS by targeting CD2AP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-026-00644-3","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T03:22:15Z","timestamp":1770607335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical value of miR-551b-5p in children with primary nephrotic syndrome and its regulatory role in disease progression"],"prefix":"10.1186","volume":"163","author":[{"given":"Yuehong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"issue":"12","key":"644_CR1","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/nep.12702","volume":"21","author":"M Jiang","year":"2016","unstructured":"Jiang M, Xiao Z, Rong L, Xu Y, Chen L, Mo Y, et al. Twenty-eight-year review of childhood renal diseases from renal biopsy data: a single centre in China. Nephrology (Carlton). 2016;21(12):1003\u20139.","journal-title":"Nephrology (Carlton)"},{"key":"644_CR2","doi-asserted-by":"crossref","unstructured":"Li FX, Hou YL, Zhou LS, Dong Y, Zhao JW, Li ZXJAPM. The status and model of children primary nephrotic syndrome in continuing nursing. Annals Palliat Med. 2021;10(3):2398407\u20132407.","DOI":"10.21037\/apm-19-480"},{"issue":"1","key":"644_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12882-023-03160-y","volume":"24","author":"Z Wang","year":"2023","unstructured":"Wang Z, Tang HY, Lin Q, Li XZ. Incidence of thromboembolism in children with primary nephrotic syndrome: a systematic review and metaanalysis. BMC Nephrol. 2023;24(1):120.","journal-title":"BMC Nephrol"},{"issue":"5","key":"644_CR4","first-page":"466","volume":"24","author":"J Tu","year":"2022","unstructured":"Tu J, Chen CY, Geng HY, Li HR, Xia H, Lin Y, et al. [Clinical assessment of moderate-dose glucocorticoid in the treatment of recurrence of primary nephrotic syndrome in children: a prospective randomized controlled trial]. Zhongguo Dang Dai Er Ke Za Zhi. 2022;24(5):466\u201371.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"644_CR5","doi-asserted-by":"crossref","unstructured":"Wang L, Wang J, Wang Z, Zhou J, Zhang Y. Higher urine Exosomal miR-193a is associated with a higher probability of primary focal segmental glomerulosclerosis and an increased risk of poor prognosis among children with nephrotic syndrome. Front Cell Dev Biol. 2021; 9727370.","DOI":"10.3389\/fcell.2021.727370"},{"issue":"3","key":"644_CR6","first-page":"1772","volume":"13","author":"C Xu","year":"2021","unstructured":"Xu C, Li Y. Effects of mir-151-3p-mediated GLCCl1 expression on biological function in children with nephrotic syndrome. Am J Transl Res. 2021;13(3):1772\u20138.","journal-title":"Am J Transl Res"},{"key":"644_CR7","doi-asserted-by":"crossref","unstructured":"Kochuthakidiyel Suresh P, Venkatachalapathy Y, C GPD, Geminiganesan S, Ekambaram S, C DM. Molecular insights into steroid resistance in childhood nephrotic syndrome: gene expression and prognostic MiRNA signatures. Comput Biol Chem. 2025; 119108584.","DOI":"10.1016\/j.compbiolchem.2025.108584"},{"key":"644_CR8","doi-asserted-by":"crossref","unstructured":"Chen S, Liu C, He Y, Zhao T, Yu S, Wang Z et al. Predicting and validating the regulation of podocyte injury and treatment of diabetic kidney disease by Yinhuo Tang. J Vis Exp. 2025; (220).","DOI":"10.3791\/67939"},{"issue":"1","key":"644_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40035-024-00454-5","volume":"13","author":"YY Xue","year":"2024","unstructured":"Xue YY, Zhang ZS, Lin RR, Huang HF, Zhu KQ, Chen DF, et al. CD2AP deficiency aggravates alzheimer\u2019s disease phenotypes and pathology through p38 MAPK activation. Transl Neurodegener. 2024;13(1):64.","journal-title":"Transl Neurodegener"},{"issue":"10","key":"644_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07094-7","volume":"15","author":"L Zhang","year":"2024","unstructured":"Zhang L, He J, Zhao W, Zhou Y, Li J, Li S, et al. CD2AP promotes the progression of glioblastoma multiforme via TRIM5-mediated NF-kB signaling. Cell Death Dis. 2024;15(10):722.","journal-title":"Cell Death Dis"},{"issue":"1","key":"644_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00852-x","volume":"20","author":"M Vandal","year":"2025","unstructured":"Vandal M, Janmaleki M, Rea I, Gunn C, Hirai S, Biernaskie J, et al. CD2AP at the junction of nephropathy and Alzheimer\u2019s disease. Mol Neurodegener. 2025;20(1):63.","journal-title":"Mol Neurodegener"},{"issue":"4","key":"644_CR12","doi-asserted-by":"publisher","first-page":"e7055","DOI":"10.1002\/cam4.7055","volume":"13","author":"C Chen","year":"2024","unstructured":"Chen C, Xu J, Zhang JX, Chen LY, Wei YA, Zhang WM, et al. CD2AP is a potential prognostic biomarker of renal clear cell carcinoma. Cancer Med. 2024;13(4):e7055.","journal-title":"Cancer Med"},{"issue":"10","key":"644_CR13","first-page":"729","volume":"55","author":"[Evidence-based guideline on","year":"2017","unstructured":"[Evidence-based guideline on. Diagnosis and treatment of steroid-sensitive, relapsing\/steroid-dependent nephrotic syndrome in children(2016)]. Zhonghua Er Ke Za Zhi. 2017;55(10):729\u201334.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"9","key":"644_CR14","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1681\/ASN.2020111583","volume":"32","author":"AS Go","year":"2021","unstructured":"Go AS, Tan TC, Chertow GM, Ordonez JD, Fan D, Law D, et al. Primary nephrotic syndrome and risks of ESKD, cardiovascular events, and death: the Kaiser Permanente nephrotic syndrome study. J Am Soc Nephrol. 2021;32(9):2303\u201314.","journal-title":"J Am Soc Nephrol"},{"key":"644_CR15","doi-asserted-by":"crossref","unstructured":"Wei H, Zhao H, Cheng D, Zhu Z, Xia Z, Lu D, et al. miR-148a and miR-551b-5p regulate inflammatory responses via regulating autophagy in acute pancreatitis. Int Immunopharmacol. 2024;127111438.","DOI":"10.1016\/j.intimp.2023.111438"},{"key":"644_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105941","volume":"174","author":"ZQ Jin","year":"2021","unstructured":"Jin ZQ. MicroRNA targets and biomarker validation for diabetes-associated cardiac fibrosis. Pharmacol Res. 2021;174:105941.","journal-title":"Pharmacol Res"},{"key":"644_CR17","unstructured":"Young M, Leslie SW. Renal Biopsy. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Stephen Leslie declares no relevant financial relationships with ineligible companies.: StatPearls publishing copyright \u00a9 2025. StatPearls Publishing LLC.; 2025."},{"issue":"4","key":"644_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10157-024-02595-3","volume":"29","author":"A Sinha","year":"2025","unstructured":"Sinha A, Sra M, Ahmed A, Mallick S, Saini H, Devi KG, et al. MicroRNAs in idiopathic childhood nephrotic syndrome. Clin Exp Nephrol. 2025;29(4):477\u201384.","journal-title":"Clin Exp Nephrol"},{"key":"644_CR19","unstructured":"Chen W, Chen D, Yafei Z, Yaoyao Z, Juan L, Fengjun G. Analysis of the relationship between serum CTLA4, S100A12 Levels, disease Condition, and prognosis in children with primary nephrotic syndrome. Chin J Diffic and Compl Cas. 2025;24(02):203\u20138."},{"issue":"7","key":"644_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019106","volume":"99","author":"Y Huang","year":"2020","unstructured":"Huang Y, Feng L, Li X, Huang S, Deng Y, Liang ZE, et al. Clinical observation and analysis of thyroid hormone levels in patients with idiopathic membranous nephropathy. Medicine (Baltimore). 2020;99(7):e19106.","journal-title":"Medicine (Baltimore)"},{"key":"644_CR21","doi-asserted-by":"crossref","unstructured":"Zheng Z, Chen G, Jing X, Liu L, Yang LJTP. The risk factors for children with primary nephrotic syndrome: a systematic review and meta-analysis. Transl Pediatr. 2021;10(12):3184.","DOI":"10.21037\/tp-21-468"},{"key":"644_CR22","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.19917","volume":"13","author":"H Li","year":"2025","unstructured":"Li H, Qian C, Huang J, Sun M. Inflammatory and nutritional indexes as predictors of acute kidney injury in patients with Immunoglobulin A nephropathy: a retrospective study. PeerJ. 2025;13:e19917.","journal-title":"PeerJ"},{"issue":"6","key":"644_CR23","doi-asserted-by":"publisher","first-page":"e787","DOI":"10.34067\/KID.0000000000000143","volume":"4","author":"H Kuno","year":"2023","unstructured":"Kuno H, Kanzaki G, Sasaki T, Haruhara K, Okabe M, Yokote S, et al. High albumin clearance predicts the minimal change nephrotic syndrome relapse. Kidney360. 2023;4(6):e787\u201395.","journal-title":"Kidney360"},{"issue":"1","key":"644_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-024-03242-3","volume":"24","author":"T Li","year":"2024","unstructured":"Li T, Ma X, Wang T, Tian W, Liu J, Shen W, et al. Clostridium butyricum inhibits the inflammation in children with primary nephrotic syndrome by regulating Th17\/Tregs balance via gut-kidney axis. BMC Microbiol. 2024;24(1):97.","journal-title":"BMC Microbiol"},{"issue":"11","key":"644_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112978","volume":"11","author":"C Gluhovschi","year":"2023","unstructured":"Gluhovschi C, Gadalean F, Velciov S, Nistor M, Petrica LJB. Three diseases mediated by different immunopathologic mechanisms\u2014ANCA-associated vasculitis, anti-glomerular basement membrane disease, and immune complex-mediated glomerulonephritis\u2014a common clinical and histopathologic picture: rapidly progressive crescentic glomerulonephritis. Biomedicines. 2023;11(11):2978.","journal-title":"Biomedicines"},{"key":"644_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.783282","volume":"12","author":"N Skartsis","year":"2021","unstructured":"Skartsis N, Peng Y, Ferreira LMR, Nguyen V, Ronin E, Muller YD, et al. IL-6 and TNF\u03b1 drive extensive proliferation of human Tregs without compromising their lineage stability or function. Front Immunol. 2021;12:783282.","journal-title":"Front Immunol"},{"key":"644_CR27","volume":"2021","author":"B Wang","year":"2021","unstructured":"Wang B, Yu P, Lin W, Zhai Z. MicroRNA-21-5p reduces hypoxia\/reoxygenation-induced neuronal cell damage through negative regulation of CPEB3. Anal Cell Pathol (Amst). 2021;2021:5543212.","journal-title":"Anal Cell Pathol (Amst)"},{"issue":"6","key":"644_CR28","doi-asserted-by":"publisher","DOI":"10.2174\/0115733998270983231009094216","volume":"20","author":"B Rai","year":"2024","unstructured":"Rai B, Srivastava J, Saxena P. The functional role of microRNAs and mRNAs in diabetic kidney disease: a review. Curr Diabetes Rev. 2024;20(6):e201023222412.","journal-title":"Curr Diabetes Rev"},{"issue":"10","key":"644_CR29","doi-asserted-by":"publisher","first-page":"16516","DOI":"10.1002\/jcb.28911","volume":"120","author":"L Ming","year":"2019","unstructured":"Ming L, Ning J, Ge Y, Zhang Y, Ruan ZJ. Excessive apoptosis of podocytes caused by dysregulation of microRNA-182\u20105p and CD2AP confers to an increased risk of diabetic nephropathy. J Cell Biochem. 2019;120(10):16516\u201323.","journal-title":"J Cell Biochem"},{"issue":"7","key":"644_CR30","doi-asserted-by":"publisher","first-page":"11366","DOI":"10.1002\/jcb.28413","volume":"120","author":"JY Wang","year":"2019","unstructured":"Wang JY, Zhang DQ, Cao Q, Qiao XQ, Zhou GP. miR-939\u20105p decreases the enrichment of RNA polymerase II in the promoter region of CD2AP involved in nephrotic syndrome. J Cell Biochem. 2019;120(7):11366\u201374.","journal-title":"J Cell Biochem"},{"issue":"4","key":"644_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s44307-024-00051-7","volume":"2","author":"P Li","year":"2024","unstructured":"Li P, Liang D, Yang E, Zeb M, Huang H, Sun H, et al. Bio-nanopore technology for biomolecules detection. Adv Biotechnol. 2024;2(4):45.","journal-title":"Adv Biotechnol"},{"issue":"1","key":"644_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s44307-024-00010-2","volume":"2","author":"S Lu","year":"2024","unstructured":"Lu S, Tang Y, Yin S, Sun LJ. RNA structure: implications in viral infections and neurodegenerative diseases. Adv Biotechnol. 2024;2(1):3.","journal-title":"Adv Biotechnol"},{"key":"644_CR33","doi-asserted-by":"crossref","unstructured":"Luo H, Yao J, Zhang R. Harnessing RNA base editing for diverse applications in RNA biology and RNA. Adv Biotechnol. 2025;3(2):11.","DOI":"10.1007\/s44307-025-00063-x"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-026-00644-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00644-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00644-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:54:23Z","timestamp":1781632463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-026-00644-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["644"],"URL":"https:\/\/doi.org\/10.1186\/s41065-026-00644-3","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol was reviewed and approved by the Ethics Committee of Shanxi Children\u2019s Hospital and Shanxi Children\u2019s Hospital. The procedures used in this study adhere to the tenets of the Declaration of Helsinki. Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}